DID YOU KNOW?
- Facet’s strategic and tactical regulatory affairs, statistics, regulatory writing, and commercialization experts lead small organizations to faster and more efficient product development, US registration, and commercial launch.
- Facet has used statistical modeling and simulations to greatly improve clinical trial success in Phase 2 and Phase 3.
- Facet’s regulatory experts set the strategy and lead the tactical plans to prepare and submit 3-5 US marketing applications each year.
- Preparations for commercial launch and reimbursement are a necessary part of product development. Even if you are not planning to take your product to US approval, a robust commercialization plan adds value to your asset and helps you communicate with potential acquirers/partners.